Search results
Found 41919 matches for
Today, the University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials of a vaccine against SARS-CoV-2 across two different dose regimens, resulting in an average efficacy of 70.4%. The new study published in the Lancet is the first peer-reviewed publication of phase 3 data from studies of a vaccine against the coronavirus.
Ellie (Eleanor) Barnes
BSc. MBBS. PhD, FRCP. FMedSci. Ellie (Eleanor) Barnes - Professor of Hepatology and Experimental Medicine
Peter Horby
FRS Peter Horby - Moh Family Foundation Professor of Emerging Infections and Global Health
Rose McGready
Rose McGready - Professor of Tropical Maternal and Child Health
Frank Smithuis
Frank Smithuis - Professor of Tropical Medicine
Louise Thwaites
BSc MBBS MRCP MD DMSMed MLCOM Louise Thwaites - Professor of Experimental Critical Care
Catherine (Sassy) Molyneux
Catherine (Sassy) Molyneux - Professor of Global Health